baltimore conference logo
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Clinical Cases in HER2+ Breast Cancer

Experts in breast oncology review 3 clinical cases of HER2+ breast cancer and discuss individualized treatment approaches for each patient.

EP. 1: Case 1: Early Stage HER2+ Breast Cancer

September 11th 2020

EP. 2: Case 1: Molecular Testing for HER2+ Breast Cancer

September 11th 2020

EP. 3: Case 1: Neoadjuvant Therapy for Early-Stage HER2+ Breast Cancer

September 11th 2020

EP. 4: Case 1: Choosing Therapy for Early Stage HER2+ Breast Cancer 

September 11th 2020

EP. 5: Case 1: Adjuvant Treatment for Residual Disease in Early Stage HER2+ Breast Cancer 

September 11th 2020

EP. 6: Case 1: Adjuvant Therapy After pCR in Early Stage HER2+ Breast Cancer 

September 11th 2020

EP. 7: Case 1: Adjuvant Trials for HER2+ Breast Cancer

September 11th 2020

EP. 8: Case 1: De-Escalation of Adjuvant Anti-HER2 Therapy for Breast Cancer 

September 11th 2020

EP. 9: Case 1: Subcutaneous Trastuzumab-Pertuzumab for HER2+ Breast Cancer 

September 11th 2020

EP. 10: Case 2: Relapsed/Refractory HR-/HER2+ Breast Cancer

September 11th 2020